Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

By T. Schnitzer, G. Burmester, E. Mysler, M. Hochberg, M. Doherty, E. Ehrsam, X. Gitton, G. Krammer, B. Mellein, P. Matchaba and 2 more. The Lancet, 2004

688 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pharmacology, Surgery

View Paper: https://www.semanticscholar.org/paper/44a4d72269f8cd56c773ac3cc9c616a27f7c617e